Strados Labs

Strados Labs is a medical technology company located in Philadelphia, Pennsylvania. The company focuses on developing smart sensor platforms that utilize machine learning and proprietary algorithms to monitor and predict conditions related to chronic respiratory diseases. Their mission is to enhance patient lives globally through innovative respiratory health monitoring solutions. The flagship product, the RESP® Biosensor, is a wearable stethoscope and respiratory monitor that continuously captures lung sounds, such as coughs and wheezes, during patients' daily activities. This device allows clinicians and researchers to remotely monitor respiratory symptoms, aiding in disease management and clinical trial assessments for conditions like asthma and COPD. The RESP Biosensor is FDA Class II 510(k) cleared and complies with HIPAA and GDPR standards. Strados Labs serves life sciences organizations, including drug developers and clinical trial teams, by providing a user-friendly device that supports decentralized clinical trials. The company collaborates with academic institutions and healthcare providers to expand research applications, including monitoring cystic fibrosis patients at home. With a dedicated team and approximately $6.4 million in funding, Strados Labs is committed to advancing respiratory disease management and clinical research.

• Employees 46
• Founded 2016
• Total Funding $11654530